FDA Grants Seventh Approval under the National Priority Voucher Pilot Program

🌐 fda.gov —

AI Summary

The FDA has granted approval for a new drug aimed at treating advanced cholangiocarcinoma, showcasing the organization's ongoing commitment to prioritizing critical medical advancements.

Bizengri is the first drug approved for adults with advanced, unresectable or metastatic cholangiocarcinoma harboring a neuregulin 1 (NRG1) gene ...

Health FDA drug approval cholangiocarcinoma medical advancements

Read original source →